Boston Scientific Corp.
(NYSE : BSX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 12.14%23.4710.1%$1285.83m
TMOThermo Fisher Scientific, Inc. -0.09%381.941.0%$571.00m
MDTMedtronic Plc -0.94%92.330.6%$566.34m
DXCMDexCom, Inc. 1.12%427.948.3%$536.23m
BDXBecton, Dickinson & Co. 0.09%250.701.0%$525.20m
ABTAbbott Laboratories -0.22%92.770.8%$524.60m
DHRDanaher Corp. -0.22%182.590.7%$454.88m
BSXBoston Scientific Corp. -1.83%34.941.0%$429.22m
QDELQuidel Corp. -4.48%225.027.7%$380.52m
ISRGIntuitive Surgical, Inc. -0.56%581.352.4%$356.39m
SYKStryker Corp. -0.54%182.901.3%$321.17m
BAXBaxter International, Inc. -2.49%85.921.8%$281.56m
ALGNAlign Technology, Inc. -2.15%276.376.3%$257.97m
EWEdwards Lifesciences Corp. -0.35%69.290.4%$211.77m
ZBHZimmer Biomet Holdings, Inc. 0.47%118.621.7%$211.36m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.